Misight 1 day contact lenses by Coopervision.
In 2019 MiSight was FDA approval for myopia control in children ages 8-12, and is currently the only product on the market that is FDA approved specifically for myopia control.
Misight lenses incorporate a dual-focus design where the center of the lens corrects vision, while the surrounding areas create a peripheral defocus. This mechanism helps slow the progression of myopia by reducing the stimulus for the eye to elongate, which is a key factor in worsening nearsightedness.
Another advantage of MiSight is its ease of use. These daily replacement schedule promotes good hygiene and comfort, making them a practical choice for kids and their parents.
Clinical studies have shown that misight lenses reduce myopia progression by 59% on average.